Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma

Elizabeth C. Smyth (Lead / Corresponding author), Russell D. Petty

Research output: Contribution to journalComment/debatepeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)97-98
Number of pages2
JournalThe Lancet
Volume392
Issue number10142
Early online date4 Jun 2018
DOIs
Publication statusPublished - 14 Jul 2018

Cite this